Participants in the double-blind study were randomly placed in one of two groups — one group used both an active nicotine patch and a nicotine inhaler while the other group used an active nicotine patch and a placebo inhaler. Both groups were instructed to use the inhalers for six months.
One month after the study completed, 31.71 percent of the smokers who used a nicotine inhaler had quit smoking, compared to 17.97 percent in the group who used a placebo inhaler.
“Currently most smokers use nicotine patches to help them stop smoking. This study shows that if you add a nicotine inhaler to a nicotine patch, it doubles the chances of quitting over a nicotine patch alone,” said co-author Julian Crane, MBBS.
More articles on smoking:
California bumps smoking age from 18 to 21
FDA announces new e-cigarette regulations: 6 things to know
Medicaid programs come up short in helping smokers quit, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
